CLARENCE E COKER

Allopathic & Osteopathic Physicians|Family Medicine LEXINGTON, SC NPI 1003891508

General Payments — all program years on this page

$6,029.33

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 438
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $324.77 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $324.7721

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $2,058.20169
2019 $1,957.00148
2020 $326.6023
2021 $204.9214
2022 $1,157.8463
2023 $324.7721

Records — PY2023 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1000111081 Bayer Healthcare Pharmaceuticals Inc. $17.74 09/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1000906763 Novo Nordisk Inc $14.87 09/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011718195 AstraZeneca Pharmaceuticals LP $13.86 09/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015018033 AstraZeneca Pharmaceuticals LP $13.86 04/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015063653 AstraZeneca Pharmaceuticals LP $13.86 03/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015248131 AstraZeneca Pharmaceuticals LP $13.86 08/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015892457 AstraZeneca Pharmaceuticals LP $13.86 02/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1017038357 Alexion Pharmaceuticals, Inc. $21.76 08/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1018697103 Abbott Laboratories $19.34 03/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1018703813 Abbott Laboratories $19.56 07/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1023194259 Edwards Lifesciences Corporation $13.06 03/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1026519975 Exact Sciences Corporation $13.82 03/31/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031324279 Lilly USA, LLC $13.43 06/05/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031429665 Lilly USA, LLC $14.56 03/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031441639 Lilly USA, LLC $13.86 10/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034565015 Astellas Pharma US Inc $14.69 10/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049886551 SANOFI-AVENTIS U.S. LLC $14.30 03/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050381191 PFIZER INC. $17.89 05/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057213657 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.89 09/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057330881 Salix Pharmaceuticals, a division of Bausch Health US, LLC $12.95 07/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996484511 AbbVie Inc. $18.75 04/18/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.